Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCL16 maintains stem cell-like properties in breast cancer by activating CCR2/GSK3β/β-catenin/OCT4 axis. | Theranostics | 2021 | 33500726 | PubTator, text mining | PubMed |
| Lumican inhibits immune escape and carcinogenic pathways in colorectal adenocarcinoma. | Aging (Albany NY) | 2021 | 33493133 | PubTator, text mining | PubMed |
| A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner. | Angiogenesis | 2021 | 33484377 | PubTator, text mining | PubMed |
| Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients. | Sci Rep | 2021 | 33479266 | PubTator, text mining | PubMed |
| Transcriptional and functional characterization of neonatal circulating Innate Lymphoid Cells. | Stem Cells Transl Med | 2021 | 33475258 | PubTator, text mining | PubMed |
| Regulatory T cells in ischemic stroke. | CNS Neurosci Ther | 2021 | 33470530 | PubTator, text mining | PubMed |
| A High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer. | Cancers (Basel) | 2021 | 33467084 | PubTator, text mining | PubMed |
Chemokine (C-C Motif) Ligand 1 Derived from Tumor-Associated Macrophages Contributes to Esophageal Squamous Cell Carcinoma Progression via CCR8-Mediated Akt/Proline-Rich Akt Substrate of 40 kDa/Mammalian Target of Rapamycin Pathway. | Am J Pathol | 2021 | 33460563 | PubTator, text mining | PubMed |
| Tissue-Resident Memory CD8+ T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis. | Arthritis Rheumatol | 2021 | 33452865 | PubTator, text mining | PubMed |
| PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma. | Onco Targets Ther | 2021 | 33447054 | PubTator, text mining | PubMed |
| Tsukushi is a novel prognostic biomarker and correlates with tumor-infiltrating B cells in non-small cell lung cancer. | Aging (Albany NY) | 2021 | 33428594 | PubTator, text mining | PubMed |
| Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma. | BMC Cancer | 2021 | 33402128 | PubTator, text mining | PubMed |
| Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge. | NPJ Vaccines | 2021 | 33398010 | PubTator, text mining | PubMed |
| Palladium-catalyzed cross-coupling reactions on a bromo-naphthalene scaffold in the search for novel human CC chemokine receptor 8 (CCR8) antagonists. | Bioorg Chem | 2021 | 33383325 | PubTator, text mining | PubMed |
| CXCL10 is a potential biomarker and associated with immune infiltration in human papillary thyroid cancer. | Biosci Rep | 2021 | 33345267 | PubTator, text mining | PubMed |
| CXCR4-Binding Positron Emission Tomography Tracers Link Monocyte Recruitment and Endothelial Injury in Murine Atherosclerosis. | Arterioscler Thromb Vasc Biol | 2021 | 33327748 | PubTator, text mining | PubMed |
| The deubiquitinase CYLD controls protective immunity against helminth infection by regulation of Treg cell plasticity. | J Allergy Clin Immunol | 2021 | 33309741 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of psoriatic skin identifies pathogenic Tc17 cell subsets and reveals distinctions between CD8+ T cells in autoimmunity and cancer. | J Allergy Clin Immunol | 2021 | 33309739 | PubTator, text mining | PubMed |
| Prognostic and immunological role of Fam20C in pan-cancer. | Biosci Rep | 2021 | 33306121 | PubTator, text mining | PubMed |
| Interleukin-8 Receptors CXCR1 and CXCR2 Are Not Expressed by Endothelial Colony-forming Cells. | Stem Cell Rev Rep | 2021 | 33185837 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=56